Dyadic International (DYAI) Preferred Shares (2025)
Dyadic International's (DYAI) quarterly Preferred Shares came in at $5.0 million in Q4 2025.
Powered by 
Analysis
Dyadic International (DYAI) Preferred Shares (2025) Analysis & Trends
Dyadic International has disclosed Preferred Shares across 1 years of filings, most recently posting $5.0 million for Q4 2025.
- In Q4 2025, Preferred Shares changed N/A year-over-year to $5.0 million; the TTM figure through Dec 2025 stood at $5.0 million (changed N/A YoY), while the FY2025 annual figure was $5.0 million, changed N/A from the prior year.
- Preferred Shares came in at $5.0 million for Q4 2025 at Dyadic International.
- In the past five years, Preferred Shares ranged from a high of $5.0 million in Q4 2025 to a low of $5.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.46 Bn | 192.47 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.92 Bn | 176.75 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 131.37 Bn | 123.51 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.86 Bn | 73.87 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.29 Bn | 55.10 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.76 Bn | 48.62 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.16 Bn | 29.85 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.90 Bn | 30.62 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.13 Bn | 29.13 Bn | 1.16 Mn | - |
| 10 | Dyadic International | 18.38 Mn | 10.42 Mn | - | - |